Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Motor Activity 236Breast Neoplasms 128Neoplasms 103Prostatic Neoplasms 35Fatigue 34Obesity 24Lung Neoplasms 23Colorectal Neoplasms 22Polycystic Ovary Syndrome 17Colonic Neoplasms 16Ovarian Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Pancreatic Neoplasms 11Lymphoma 11Carcinoma, Non-Small-Cell Lung 11Weight Loss 10Rectal Neoplasms 10Multiple Myeloma 10Lymphedema 10Hematologic Neoplasms 10Head and Neck Neoplasms 10Leukemia 9Insulin Resistance 8Cardiotoxicity 8Stomach Neoplasms 7Peripheral Nervous System Diseases 6Cognitive Dysfunction 6Cachexia 6Brain Neoplasms 6Overweight 5

Interventions

Nebivolol 1Methods 1Exercise Therapy 1Exercise 1Electrocardiography 1Echocardiography 1(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Ventricular Dysfunction, Left × Exercise × Clear all
NCT03850171 2023-02-27

Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study

Insel Gruppe AG, University Hospital Bern

Phase NA Terminated
57 enrolled
BreastLymphoid

Breast Diseases, Breast Neoplasms, Heart Failure, Lymphoma, Motor Activity, Ventricular Dysfunction, Left, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡